| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2006;114:894-904.)
© 2006 American Heart Association, Inc.
Health Services and Outcomes Research |
From the Division of Cardiology, Department of Medicine, Cedars-Sinai Research Institute, Cedars-Sinai Medical Center, Los Angeles, Calif (L.J.S., C.N.B.M.); Division of Cardiology, Department of Medicine, University of Florida, Gainesville (C.J.P.); Cardiovascular Institute, University of Pittsburgh Medical Center, Pittsburgh, Pa (S.E.R.); Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pa (K.E.K., S.F.K., M.O., B.D.J.); Division of Cardiology, Department of Medicine, Allegheny University of the Health Sciences, Pittsburgh, Pa (S.M.); Division of Cardiology, Rhode Island Hospital, Providence, RI (B.L.S.); Division of Cardiovascular Disease, Department of Medicine, University of Alabama at Birmingham (V.B., W.J.R.); Division of Cardiology, University of Southern California, Los Angeles (G.M.P.); and National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Md (G.S.).
Correspondence to Leslee J. Shaw, Emory University School of Medicine, Suite 1-North, 1256 Briarcliff Rd NE, Atlanta, GA 30306. E-mail leslee.shaw{at}emory.edu
Received December 30, 2005; revision received May 23, 2006; accepted June 22, 2006.
Background Coronary angiography is one of the most frequently performed procedures in women; however, nonobstructive (ie, <50% stenosis) coronary artery disease (CAD) is frequently reported. Few data exist regarding the type and intensity of resource consumption in women with chest pain after coronary angiography.
Methods and Results A total of 883 women referred for coronary angiography were prospectively enrolled in the National Institutes of HealthNational Heart, Lung, and Blood Institutesponsored Womens Ischemia Syndrome Evaluation (WISE). Cardiovascular prognosis and cost data were collected. Direct (hospitalizations, office visits, procedures, and drug utilization) and indirect (out-of-pocket, lost productivity, and travel) costs were estimated through 5 years of follow-up. Among 883 women, 62%, 17%, 11%, and 10% had nonobstructive and 1-vessel, 2-vessel, and 3-vessel CAD, respectively. Five-year cardiovascular death or myocardial infarction rates ranged from 4% to 38% for women with nonobstructive to 3-vessel CAD (P<0.0001). Five-year rates of hospitalization for chest pain occurred in 20% of women with nonobstructive CAD, increasing to 38% to 55% for women with 1-vessel to 3-vessel CAD (P<0.0001). The volume of repeat catheterizations or angina hospitalizations was 1.8-fold higher in women with nonobstructive versus 1-vessel CAD after 1 year of follow-up (P<0.0001). Drug treatment was highest for those with nonobstructive or 1-vessel CAD (P<0.0001). The proportion of costs for anti-ischemic therapy was higher for women with nonobstructive CAD (15% versus 12% for 1-vessel to 3-vessel CAD; P=0.001). For women with nonobstructive CAD, average lifetime cost estimates were $767 288 (95% CI, $708 480 to $826 097) and ranged from $1 001 493 to $1 051 302 for women with 1-vessel to 3-vessel CAD (P=0.0003).
Conclusions Symptom-driven care is costly even for women with nonobstructive CAD. Our lifetime estimates for costs of cardiovascular care identify a significant subset of women who are unaccounted for within current estimates of the economic burden of coronary heart disease.
Related Article:
This article has been cited by other articles:
![]() |
L. J. Shaw, R. E. Shaw, C. N. B. Merz, R. G. Brindis, L. W. Klein, B. Nallamothu, P. S. Douglas, R. J. Krone, C. R. McKay, P. C. Block, et al. Impact of Ethnicity and Gender Differences on Angiographic Coronary Artery Disease Prevalence and In-Hospital Mortality in the American College of Cardiology-National Cardiovascular Data Registry Circulation, April 8, 2008; 117(14): 1787 - 1801. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Bittner Angina Pectoris: Reversal of the Gender Gap Circulation, March 25, 2008; 117(12): 1505 - 1507. [Full Text] [PDF] |
||||
![]() |
W. Rosamond, K. Flegal, K. Furie, A. Go, K. Greenlund, N. Haase, S. M. Hailpern, M. Ho, V. Howard, B. Kissela, et al. Heart Disease and Stroke Statistics--2008 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Circulation, January 29, 2008; 117(4): e25 - e146. [Full Text] [PDF] |
||||
![]() |
R. P. Giugliano and E. Braunwald The Year in Non ST-Segment Elevation Acute Coronary Syndrome J. Am. Coll. Cardiol., October 2, 2007; 50(14): 1386 - 1395. [Full Text] [PDF] |
||||
![]() |
T. D. Henry, C. L. Grines, M. W. Watkins, N. Dib, G. Barbeau, R. Moreadith, T. Andrasfay, and R. L. Engler Effects of Ad5FGF-4 in Patients With Angina: An Analysis of Pooled Data From the AGENT-3 and AGENT-4 Trials J. Am. Coll. Cardiol., September 11, 2007; 50(11): 1038 - 1046. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Rosamond, K. Flegal, G. Friday, K. Furie, A. Go, K. Greenlund, N. Haase, M. Ho, V. Howard, B. Kissela, et al. Heart Disease and Stroke Statistics--2007 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Circulation, February 6, 2007; 115(5): e69 - e171. [Full Text] [PDF] |
||||
![]() |
Women with Ischemic Symptoms and Nonobstructive CAD Journal Watch Cardiology, October 4, 2006; 2006(1004): 6 - 6. [Full Text] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |